JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on September 21, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/39/36241    most recent
M104319200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thirunavukkarasu, K.
Right arrow Articles by Onyia, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thirunavukkarasu, K.
Right arrow Articles by Onyia, J. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print July 12, 2001
J. Biol. Chem, 10.1074/jbc.M104319200
Submitted on May 11, 2001
Revised on July 12, 2001
Accepted on July 12, 2001

Stimulation of osteoprotegerin (OPG) gene expression by transforming growthfactor-beta (TGF-beta): Mapping of the OPG promoter region that mediates TGF-betaeffects

Kannan Thirunavukkarasu, Rebeccca R. Miles, David L. Halladay, Xuhao Yang, Rachelle J.S. Galvin, S. Chandrasekhar, T. John Martin, and Jude E. Onyia

Gene Regulation, Bone and Inflammation Research, Eli Lilly and Company, Indianapolis, IN 46258

Corresponding Author: jeo{at}lilly.com

Transforming growth factor-¦Â (TGF-¦Â ) regulates osteoclastogenesis and osteoclast survival, in part through the induction of osteoprotegerin (OPG), a protein known to inhibit osteoclast formation and function. To explore the molecular basis of TGF-¦Â regulation of OPG expression, we evaluated the effects of TGF-¦Â on osteoclast formation, OPG protein secretion, mRNA expression and gene transcription. The marked inhibitory effect of TGF-¦Â on osteoclast differentiation was confirmed in a co-culture model utilizing murine stromal/osteoblastic BALC cells and bone marrow hematopoietic precursors. This inhibition in osteoclast differentiation was preceded by a decrease in RANKL mRNA expression (5-fold) and a reciprocal increase in OPG mRNA (6.1-fold) and protein (7.1-fold) expression in BALC cells. At the promoter/transcriptional level, TGF-¦Â treatment resulted in a 3- to 10-fold increase in reporter gene activity directed by a 5.9-kb fragment of the human OPG promoter in transfection assays performed in UMR106 cells. The effect of TGF-¦Â was mimicked by TGF-¦Â 2 and -“´¬–”²ª› 3, but not BMP-4,suggesting a TGF-¦Â signal-specific effect. Deletion analysis revealed that a 183-bp region (?372 to ?190) in the promoter was required for TGF-¦Â responsiveness, and this region was sufficient to confer TGF-¦Â inducibility to a heterologous (osteocalcin) minimal promoter. Substitution mutations that disrupted the Cbfa1- and/or Smad- binding elements present in the 183-bp region resulted in a decrease in baseline expression and in the responsiveness to TGF-¦Â and Cbfa1. Collectively, these studies indicate the involvement and possible interaction of Cbfa1 and Smad proteins in mediating the effects of TGF-¦Â on OPG transcription.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
A. E. Kearns, S. Khosla, and P. J. Kostenuik
Receptor Activator of Nuclear Factor {kappa}B Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease
Endocr. Rev., April 1, 2008; 29(2): 155 - 192.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
X. Tan, T. Weng, J. Zhang, J. Wang, W. Li, H. Wan, Y. Lan, X. Cheng, N. Hou, H. Liu, et al.
Smad4 is required for maintaining normal murine postnatal bone homeostasis
J. Cell Sci., July 1, 2007; 120(13): 2162 - 2170.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Li, G. Toraldo, A. Li, X. Yang, H. Zhang, W.-P. Qian, and M. N. Weitzmann
B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo
Blood, May 1, 2007; 109(9): 3839 - 3848.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
D. J. HADJIDAKIS and I. I. ANDROULAKIS
Bone Remodeling
Ann. N.Y. Acad. Sci., December 1, 2006; 1092(1): 385 - 396.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
E. ABE
Function of BMPs and BMP Antagonists in Adult Bone
Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 41 - 53.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. E. Onyia, R. J. S. Galvin, Y. L. Ma, D. L. Halladay, R. R. Miles, X. Yang, T. Fuson, R. L. Cain, Q. Q. Zeng, S. Chandrasekhar, et al.
Novel and Selective Small Molecule Stimulators of Osteoprotegerin Expression Inhibit Bone Resorption
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 369 - 379.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. A. Karsdal, P. Hjorth, K. Henriksen, T. Kirkegaard, K. L. Nielsen, H. Lou, J.-M. Delaisse, and N. T. Foged
Transforming Growth Factor-{beta} Controls Human Osteoclastogenesis through the p38 MAPK and Regulation of RANK Expression
J. Biol. Chem., November 7, 2003; 278(45): 44975 - 44987.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Viereck, C. Grundker, S. Blaschke, B. Niederkleine, H. Siggelkow, K.-H. Frosch, D. Raddatz, G. Emons, and L. C. Hofbauer
Raloxifene Concurrently Stimulates Osteoprotegerin and Inhibits Interleukin-6 Production by Human Trabecular Osteoblasts
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4206 - 4213.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. W. A. McGowan, H. MacPherson, K. Janssens, W. Van Hul, J. C. Frith, W. D. Fraser, S. H. Ralston, and M. H. Helfrich
A Mutation Affecting the Latency-Associated Peptide of TGF{beta}1 in Camurati-Engelmann Disease Enhances Osteoclast Formation in Vitro
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3321 - 3326.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Enomoto, S. Shiojiri, K. Hoshi, T. Furuichi, R. Fukuyama, C. A. Yoshida, N. Kanatani, R. Nakamura, A. Mizuno, A. Zanma, et al.
Induction of Osteoclast Differentiation by Runx2 through Receptor Activator of Nuclear Factor-{kappa}B Ligand (RANKL) and Osteoprotegerin Regulation and Partial Rescue of Osteoclastogenesis in Runx2-/- Mice by RANKL Transgene
J. Biol. Chem., June 20, 2003; 278(26): 23971 - 23977.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Chagraoui, M. Tulliez, T. Smayra, E. Komura, S. Giraudier, T. Yun, N. Lassau, W. Vainchenker, and F. Wendling
Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO
Blood, April 15, 2003; 101(8): 2983 - 2989.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Arko, J. Prezelj, R. Komel, A. Kocijancic, P. Hudler, and J. Marc
Sequence Variations in the Osteoprotegerin Gene Promoter in Patients with Postmenopausal Osteoporosis
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4080 - 4084.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
V. Geoffroy, M. Kneissel, B. Fournier, A. Boyde, and P. Matthias
High Bone Resorption in Adult Aging Transgenic Mice Overexpressing Cbfa1/Runx2 in Cells of the Osteoblastic Lineage
Mol. Cell. Biol., September 1, 2002; 22(17): 6222 - 6233.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.